-
- 抗原 See all APOO 抗体
- APOO (Apolipoprotein O (APOO))
-
抗原表位
- C-Term
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This APOO antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- FAM121 B antibody was raised against the C terminal Of Fam121
- 纯化方法
- Purified
- 免疫原
- FAM121 B antibody was raised using the C terminal Of Fam121 corresponding to a region with amino acids LYYPQQAIVFAQVSGERLYDWGLRGYIVIEDLWKENFQKPGNVKNSPGTK
- Top Product
- Discover our top product APOO Primary Antibody
-
anti-Apolipoprotein O (APOO) antibody
APOO 适用: 人, 小鼠 WB, ELISA, IHC 宿主: 小鼠 Monoclonal 2F1 unconjugated
anti-Apolipoprotein O (APOO) (AA 101-198) antibodyAPOO 适用: 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro), ICC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein O (APOO) (AA 26-198) antibodyAPOO 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein O (APOO) (N-Term) antibodyAPOO 适用: 人, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein O (APOO) (C-Term) antibodyAPOO 适用: 人, 大鼠, Cow, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein O (APOO) (AA 26-198) antibodyAPOO 适用: 人 WB, IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-Apolipoprotein O (APOO) (AA 9-38), (N-Term) antibodyAPOO 适用: 人 WB, IHC (p) 宿主: 兔 Polyclonal RB33349 unconjugated
-
- 应用备注
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
FAM121B Blocking Peptide, catalog no. 33R-5578, is also available for use as a blocking control in assays to test for specificity of this FAM121B antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FAM120 antibody in PBS
- 浓度
- Lot specific
- 缓冲液
- PBS
- 注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- 抗原
- APOO (Apolipoprotein O (APOO))
- 别名
- FAM121B (APOO 产品)
- 背景
- FAM121B belongs to the FAM121 family and the function remains unknown.
- 分子量
- 22 kDa (MW of target protein)
-
You are here:
